Stay updated with breaking news from Cingulate Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KANSAS CITY, Kan., June 14, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a... | June 15, 2023
Cingulate Inc. (NASDAQ:CING – Get Rating) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 156,700 shares, a decrease of 45.5% from the April 30th total of 287,700 shares. Based on an average trading volume of 838,400 shares, the short-interest […]
KANSAS CITY, Kan., May 25, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a... | May 25, 2023
KANSAS CITY, Kan., May 25, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed...
FinancialContent fully hosted finance channel